Cargando…

1370. Role of Clindamycin Versus Linezolid for Serious Group A Streptococcal Infections

BACKGROUND: Streptococcus pyogenes can cause severe illnesses such as toxic-shock syndrome and necrotizing fasciitis due to pyrogenic exotoxins. Clindamycin is added to penicillin for treatment of severe S. pyogenes infections as it is a bacterial protein synthesis inhibitor which reduces toxin prod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heil, Emily, Basappa, Sapna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644124/ http://dx.doi.org/10.1093/ofid/ofab466.1562

Ejemplares similares

175. Clindamycin versus linezolid for Group A Streptococcal bloodstream infections?: A comparative effectiveness study of adjunctive antitoxin therapy at 137 US Hospitals
por: Babiker, Ahmed, et al.
Publicado: (2023)

450. Evaluation of Linezolid Pharmacokinetics in Obese Patients with Severe Skin and Soft-Tissue Infections
por: Blackman, Alison L, et al.
Publicado: (2019)

1370. Three of Hearts: A Case Series and Literature Review of Pediatric Purulent Pericarditis
por: Estes, Alyssa, et al.
Publicado: (2020)

Clindamycin Plus Vancomycin Versus Linezolid for Treatment of Necrotizing Soft Tissue Infection
por: Dorazio, Joshua, et al.
Publicado: (2023)

1220. Is MIC all that matters? MIC Distributions of Ceftazidime and Cefepime in Ceftriaxone-Resistant E. coli and Klebsiella spp
por: Heil, Emily, et al.
Publicado: (2021)

1117. Tazobactam Pharmacokinetic/Pharmacodynamic Target Attainment in Healthy Volunteers and Critically-Ill Hospitalized Patients
por: Kalaria, Shamir N, et al.
Publicado: (2021)

Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis
por: Laho, Delphine, et al.
Publicado: (2021)

1370. Prevalence and predictors of post-covid-19 (long covid) in India
por: Kumar, Vignesh, et al.
Publicado: (2023)

274. Comparison of Cefazolin Susceptibilities of Enterobacterales with an Automated Susceptibility Testing Platform versus In Vitro Antimicrobial Testing
por: Noval, Mandee, et al.
Publicado: (2020)

349. Diagnostic Testing and Antibiotic Utilization in Patients with COVID-19
por: Groft, Lauren, et al.
Publicado: (2021)

P1370: A NOVEL GENE THERAPY VECTOR FOR BETA-HEMOGLOBINOPATHIES WITH A SELECTIVE EXPANSION CASSETTE
por: Kirtsou, Alexandra, et al.
Publicado: (2023)

A Cross-sectional Analysis of Linezolid in Combination with Methadone or Buprenorphine as a Cause of Serotonin Toxicity
por: Traver, Edward C, et al.
Publicado: (2022)

Immediate and Delayed Hypersensitivity Reactions to Antibiotics: Aminoglycosides, Clindamycin, Linezolid, and Metronidazole
por: Dilley, Michelle, et al.
Publicado: (2021)

1989. Surge in Group A Streptococcal Infections in England during 2022
por: Guy, Rebecca L, et al.
Publicado: (2023)

1349. Institutional Antibiograms Are Insufficient to Guide Clindamycin Use in Pediatric Skin and Soft Tissue Infections
por: Firmani, Sarah E, et al.
Publicado: (2020)

P1370: EFFECTS OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL FROM HEALTHY DONORS ON RECIPIENTS AFTER TRANSPLANTATION AND RELATED RESEARCH
por: Shen, B., et al.
Publicado: (2022)

1090. Does calculation method matter for targeting vancomycin AUC?
por: Chang, Jack, et al.
Publicado: (2021)

Randomized Clinical Trial of Intrapartum Clindamycin Cream for Reduction of Group B Streptococcal Maternal and Neonatal Colonization
por: Gibbs, R. S., et al.
Publicado: (1996)

260. A Rare Case of Severe Group B Streptococcal Infection with Toxic Shock-like Syndrome and Diffuse Metastatic Infection
por: Ayyash, Ali M, et al.
Publicado: (2020)

1096. Linezolid versus Tedizolid for the Treatment of Nontuberculous Mycobacteria in Solid Organ Transplant Recipients: An Assessment of Safety
por: Poon, Yi Kee, et al.
Publicado: (2020)

472. Rethinking the Role of Clindamycin for Toxin-Mediated Illnesses
por: Saldarriaga Perez, Carolina, et al.
Publicado: (2019)

Clindamycin but not Intravenous Immunoglobulins reduces mortality in a retrospective cohort of critically ill patients with bacteremic Group A Streptococcal infections
por: Fernández-Galilea, Adela, et al.
Publicado: (2022)

1200. Risk of group A streptococcal Transmission Among the Pediatric Population in the Houston Area
por: Alamarat, zain I, et al.
Publicado: (2020)

2362. Emergency Department Resource Utilization After Implementation of a Dalbavancin Pathway for Skin and Soft-Tissue Infections
por: Heil, Emily, et al.
Publicado: (2018)

Evidence of Streptococcal Infection in a new onset Paediatric OCD
Publicado: (2022)

192. Epidemiology, Microbiological Characteristics and Clinical Outcomes of Invasive Blood Stream Infections of Group B Streptococcal Isolates From Qatar
por: Ali, Maisa, et al.
Publicado: (2021)

117. Natural Language Processing: An Automated Alternative to Determining Inappropriate Group A Streptococcal Testing
por: Lee, Brian R, et al.
Publicado: (2020)

473. Impact of Adjunctive Clindamycin in Invasive β-Hemolytic Streptococcal Infections: A Propensity Score-matched Analysis of 1956 β-lactam Treated Patients from 118 US Hospitals
por: Babiker, Ahmed, et al.
Publicado: (2019)

694. Prediction Tool for Infective Endocarditis in Beta-hemolytic Streptococcal Bacteremia
por: Hasegawa, Ryo, et al.
Publicado: (2021)

Ceftolozane-tazobactam for the Treatment of Multi Drug-resistant Pseudomonas aeruginosa (MDRPA) Infections
por: Molnar, Esther, et al.
Publicado: (2017)

1158. Pediatric Group A Streptococcal Peritonitis: A Single-Center Eleven Patient Case Series
por: Pershing, Nicole L, et al.
Publicado: (2021)

195. Duration of Therapy for Streptococcal Bacteremia
por: Boulos, John M, et al.
Publicado: (2021)

1370. Concurrent Anti-PD -1 and Anti-tubercular Therapy in a Patient with Refractory Lymphoma and Pulmonary Tuberculosis: A Case Report
por: Rajagopal, Sumanth, et al.
Publicado: (2019)

1050. Oral Antibiotics for the Treatment of Gram-Negative Bloodstream Infections: Prescribing Practices and Outcomes at a Large Academic Medical Center
por: Claeys, Kimberly, et al.
Publicado: (2018)

2389. Assessing the Time Course of Proton Pump Inhibitor Use and Clostridioides difficile Infection
por: Panagos, Katherine, et al.
Publicado: (2019)

Gram-Negative Polymicrobial Bloodstream Infections and Clinical Decision Making with a Microarray Testing System
por: Claeys, Kimberly, et al.
Publicado: (2017)

1092. Increased Risk of Serious Infections in Mantle Cell Lymphoma Versus Other Hematologic Malignancies in Patients on Ibrutinib
por: Holowka, Thomas, et al.
Publicado: (2020)

1216. Cost-Effectiveness of Penicillin Skin Allergy Testing in Methicillin-Sensitive Staphylococcus aureus (MSSA) Bacteremia
por: Meninger, Stephen, et al.
Publicado: (2018)

814. Successful Treatment of Cutibacterium acnes (CA) Prosthetic Device Infection (PDI) with Oral Linezolid and Rifampin (LR)
por: Nahass, Ronald G, et al.
Publicado: (2021)

Emergence of Alarming Clindamycin and Erythromycin-resistant Streptococcus Group B over 2004–2016 in Kuwait
por: Al-Sweih, Noura, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ega0m2b3dt43ccpalropjp5o6b